Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
University of Washington School of Medicine specialist comments on study findings published in JAMA Network Open.
Analysis of nearly 34,000 people finds no serious adverse events associated with direct-acting antiviral therapy.
A new report says progress has been made in prevention, but global screening and treatment programs still lag.
Between August 2018 and January 2019, the FDA doubled the number of liver cancer treatments.
GS-4774 combined with Viread stimulates immune activity against the virus.
A look at the latest news and research on the subject of children with viral hepatitis.
Four things you should know to be #HepAware.
A scientific platform that acts as a catalyst to accelerate the progress for achieving a cure.
It’s Hepatitis Awareness Month. Find out if money poses a risk for transmitting viral hepatitis.
Such a vaccine would make inoculation easier in developing nations, where the need is great.
A wide variety of research studies show there are benefits of coffee consumption for hepatitis C and liver disease.
Here are 5 reasons why everyone needs to get involved during Hepatitis Awareness Month, as well as the rest of the year.
Bulevirtide plus pegylated interferon shows promise for hard-to-treat coinfection.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.